Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Non-Current Deffered Revenue (2016 - 2018)

Lemaitre Vascular (LMAT) has disclosed Non-Current Deffered Revenue for 4 consecutive years, with $530000.0 as the latest value for Q4 2018.

  • On a quarterly basis, Non-Current Deffered Revenue fell 5.53% to $530000.0 in Q4 2018 year-over-year; TTM through Dec 2018 was $530000.0, a 5.53% decrease, with the full-year FY2018 number at $530000.0, down 5.53% from a year prior.
  • Non-Current Deffered Revenue was $530000.0 for Q4 2018 at Lemaitre Vascular, down from $539000.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $561000.0 in Q4 2017 to a low of $281000.0 in Q4 2015.
  • A 4-year average of $481400.0 and a median of $532000.0 in 2017 define the central range for Non-Current Deffered Revenue.
  • Peak YoY movement for Non-Current Deffered Revenue: soared 42.39% in 2017, then dropped 5.53% in 2018.
  • Lemaitre Vascular's Non-Current Deffered Revenue stood at $281000.0 in 2015, then skyrocketed by 40.21% to $394000.0 in 2016, then surged by 42.39% to $561000.0 in 2017, then fell by 5.53% to $530000.0 in 2018.
  • Per Business Quant, the three most recent readings for LMAT's Non-Current Deffered Revenue are $530000.0 (Q4 2018), $539000.0 (Q3 2018), and $547000.0 (Q2 2018).